Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
About IGF-1R IGF-1R is a transmembrane receptor tyrosine kinase that plays a central role in regulating cell growth, proliferation, differentiation, and survival, and is involved in both normal development and disease pathophysiology
BPC (1,000 mcg) exerts its regenerative activity through VEGF-mediated angiogenesis supporting new capillary formation in healing tissue, growth hormone receptor upregulation amplifying fibroblast collagen synthesis and connective tissue repair, direct stabilization and restoration of intestinal epithelial tight junction proteins protecting and repairing the gut barrier from inflammatory and chemical damage, nitric oxide pathway activation supporting vascular and tissue perfusion, and antioxidant and inflammatory-modulating activity across multiple tissue compartments
When to choose ARA-290 ARA-290 emerges as the preferred option when: Neuropathy or nerve damage is the primary concern Systemic inflammation contributes to symptoms Previous treatments targeting pain symptoms haven't helped Nerve regeneration rather than just symptom relief is the goal Clinical trial evidence matters for decision-making Cardiovascular protection is also desired BPC-157 or TB-500 might be preferred when: Localized soft tissue injury is the focus Tendon, ligament, or muscle repair is needed Gut healing is a priority ( peptides for gut health ) General recovery and regeneration is the goal Stacking considerations Some researchers stack ARA-290 with other peptides targeting different mechanisms
The two cell types were cultured together for 7 days and the model was treated with cARLA (48 h) before the permeability assays
No, BPC-157 does not directly increase growth hormone
